[home]
[thesaurus]
Click Here to return To Results
Effect of Laquinimod on MRI-Monitored Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IIb Study
Lancet 371:2085-2092,2059, Comi,G.,etc., 2008
See this aricle in Pubmed
Article Abstract
In patients with relapsing-remitting multiple sclerosis, 0-6 mg per day laquinimod significantly reduced MRI-measured disease activity and was well tolerated.
Related Tags
(click to filter results - removes previous filter)
advances in neurology
efficacy
gadolinium
immunomodulation
laquinimod
MRI
MRI,abnormal
MRI,contrast enhanced
multiple sclerosis
multiple sclerosis,relapsing
multiple sclerosis,treatment of
safety
treatment of neurologic disorder
Click Here to return To Results